erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Abnormalities, Drug-Induced D000014 10 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Abscess D000038 13 associated lipids
Peritonsillar Abscess D000039 1 associated lipids
Acne Vulgaris D000152 35 associated lipids
Actinomycetales Infections D000193 4 associated lipids
Actinomycosis, Cervicofacial D000197 1 associated lipids
Adenocarcinoma D000230 166 associated lipids
Agammaglobulinemia D000361 4 associated lipids
Airway Obstruction D000402 13 associated lipids
Alveolitis, Extrinsic Allergic D000542 6 associated lipids
Anemia, Hemolytic, Autoimmune D000744 5 associated lipids
Anemia, Hypochromic D000747 5 associated lipids
Angiomatosis D000798 1 associated lipids
Animal Diseases D000820 2 associated lipids
Aortic Aneurysm D001014 8 associated lipids
Aortic Valve Stenosis D001024 4 associated lipids
Spider Bites D001098 1 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Infectious D001170 8 associated lipids
Asthenia D001247 5 associated lipids
Ataxia D001259 20 associated lipids
Auditory Diseases, Central D001304 2 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Bacterial Infections D001424 21 associated lipids
Bacteriuria D001437 7 associated lipids
Balanitis D001446 4 associated lipids
Bartonella Infections D001474 3 associated lipids
Bile Reflux D001655 2 associated lipids
Birth Weight D001724 23 associated lipids
Bites, Human D001734 2 associated lipids
Blepharitis D001762 4 associated lipids
Blister D001768 16 associated lipids
Body Weight D001835 333 associated lipids
Bone Resorption D001862 7 associated lipids
Boutonneuse Fever D001907 5 associated lipids
Bradycardia D001919 13 associated lipids
Bronchiectasis D001987 7 associated lipids
Bronchiolitis D001988 6 associated lipids
Bronchiolitis Obliterans D001989 8 associated lipids
Bronchopneumonia D001996 7 associated lipids
Bundle-Branch Block D002037 2 associated lipids
Bursitis D002062 3 associated lipids
Campylobacter Infections D002169 13 associated lipids
Carbuncle D002270 1 associated lipids
Cardiac Tamponade D002305 7 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Cat-Scratch Disease D002372 4 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Mortensen JE and McDowell T Streptococcus pyogenes: resistant, tolerant, neither or both? 1995 Adv. Exp. Med. Biol. pmid:8718606
Ferraro AL et al. The antimicrobial susceptibility of Streptococcus pyogenes isolates from the Philadelphia area. 1995 Adv. Exp. Med. Biol. pmid:8718607
Yang YH et al. Opacity factor inhibition test for typing group A beta-haemolytic streptococcus strains and antibiotic susceptibility. 1997 Adv. Exp. Med. Biol. pmid:9331595
Jasir A and Schalén C Erythromycin resistance phenotypes in Swedish clinical isolates of group A streptococci. 1997 Adv. Exp. Med. Biol. pmid:9331689
Savoia D et al. Group A streptococci. Erythromycin resistance and penicillin tolerance. 1997 Adv. Exp. Med. Biol. pmid:9331690
Vicarini H et al. Analysis of regulatory region of ermAM genes in streptococci and enterococci highly resistant to macrolides and lincosamides. 1997 Adv. Exp. Med. Biol. pmid:9331702
Lartey PA et al. New developments in macrolides: structures and antibacterial and prokinetic activities. 1994 Adv. Pharmacol. pmid:8080820
Garrett RA and Wittmann HG Structure of bacterial ribosomes. 1973 Adv. Protein Chem. pmid:4589667
Dully FE Streptococcal epidemic in an aircraft carrier. 1973 Aerosp Med pmid:4201795
Ogwal S and Xide TU Bioavailability and stability of erythromycin delayed release tablets. 2001 Afr Health Sci pmid:12789122
Olatunji FO et al. Non-gonococcal bacterial agents of conjunctivitis and their antibiotic susceptibility patterns in Ilorin, Nigeria. 2007 Afr J Med Med Sci pmid:18390064
Campbell G et al. A cautionary tale: delayed onset rhabdomyolysis due to erythromycin/simvastatin interaction. 2007 Age Ageing pmid:17913761
Haboubi NY et al. Duodenal mucosal morphometry of elderly patients with small intestinal bacterial overgrowth: response to antibiotic treatment. 1991 Age Ageing pmid:2028847
Roddis MJ Antibiotic-associated colitis: a retrospective study of fifteen cases. 1978 Age Ageing pmid:101026
Carević O and Djokić S Comparative studies on the effects of erythromycin A and azithromycin upon extracellular release of lysosomal enzymes in inflammatory processes. 1988 Agents Actions pmid:2847507
Friedman GD and Selby JV Epidemiological screening for potentially carcinogenic drugs. 1990 Agents Actions Suppl. pmid:2316434
LIGNY G and VIGUIE R [DESTRUCTION OF THE INTESTINAL FLORA BY ANTIBIOTIC THERAPY]. 1964 May-Jun Agressologie pmid:14185522
Hashiba H et al. Transformation of Lactobacillus helveticus subsp. jugurti with plasmid pLHR by electroporation. 1990 Agric. Biol. Chem. pmid:1368569
Chen SZ et al. [Correlation of HERG K+ channel protein expression to chemosensitivity of tumor cells to doxorubicin and its modulation by erythromycin]. 2005 Ai Zheng pmid:16086867
Takei M et al. [Studies on the mixed culture of Candida and Lactobacillus. 3. Influences of the antibiotics (EM and TM)]. 1967 Aichi Gakuin Daigaku Shigakkai Shi pmid:5236280
Sugiyama H [Experimental studies on control of dental caries. 1. Preventive effect of Erythromycin]. 1967 Aichi Gakuin Daigaku Shigakkai Shi pmid:5244796
Sugiyama H [Experimental studies on control of dental caries. 2. Erythromycin and oral microbial flora]. 1968 Aichi Gakuin Daigaku Shigakkai Shi pmid:5261349
van der Wouw PA et al. Disseminated cat-scratch disease in a patient with AIDS. 1989 AIDS pmid:2515881
Taha TE et al. A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission. 2006 AIDS pmid:16816561
Berger TG and Koehler JE Bacillary angiomatosis. 1993-1994 AIDS Clin Rev pmid:8217903
Schlecht HP et al. Images in HIV/AIDS. HIV-associated lymphogranuloma venereum proctitis. 2007 AIDS Read pmid:17396331
Warning against using erythromycin (even orally) while using protease inhibitors or certain other drugs. 2004 AIDS Treat News pmid:15595151
Wagner CM The care and management of pertussis in pediatric patients. 2001 Mar-Apr Air Med. J. pmid:11250611
Moss AA et al. Radiologic and clinical assessment of broad-spectrum antibiotic therapy in Crohn's disease. 1978 AJR Am J Roentgenol pmid:101028
Stickney RH et al. Chlamydia trachomatis: a cause of an infantile pneumonia syndrome. 1978 AJR Am J Roentgenol pmid:101061
Lauenstein TC et al. Time-resolved three-dimensional MR imaging of gastric emptying modified by IV administration of erythromycin. 2003 AJR Am J Roentgenol pmid:12704042
Simakova MG et al. [Clinical aspects, diagnosis and treatment of intrauterine infections]. 1995 Akush Ginekol (Mosk) pmid:7485765
Mezinova NN et al. [Effect of anti-chlamydial drugs on the effectiveness of the treatment of habitual abortion]. 1991 Akush Ginekol (Mosk) pmid:1951968
Mezinova NN and Chuchupalov PD [Endometrial Chlamydia infection in women with habitual abortion]. 1992 Akush Ginekol (Mosk) pmid:1476220
Kotua EN and Moroz AF [Erythromycin-ascorbinate therapy of pregnant rats with staphylococcal infections caused by staphylococcal strains both sensitive and resistant to erythromycin]. 1971 Akush Ginekol (Mosk) pmid:5138198
Kotua EN and Moroz AF [Passage of erythromycin and ristomycin into blood, placenta, fetus and amniotic fluid during various stages of pregnancy in generalized staphylococcal infection in albino rats]. 1971 Akush Ginekol (Mosk) pmid:4328638
Thornton JB and Harris JH The prevention of bacterial endocarditis. A new approach to a changing disease. 1986 Ala J Med Sci pmid:3953983
BOURICHON J [Importance of the suppository form in the administration of propionyl-erythromycin to children]. 1962 Alger Medicale pmid:13871918
LEBON J et al. [Staphylococcal diarrhea after terramycin administration; cure by erythromycin]. 1955 Alger Medicale pmid:14398597
Van Herwaarden MA et al. The effect of motilin agonist ABT-229 on gastro-oesophageal reflux, oesophageal motility and lower oesophageal sphincter characteristics in GERD patients. 2000 Aliment. Pharmacol. Ther. pmid:10759625
Russo A et al. Effect of the motilin agonist KC 11458 on gastric emptying in diabetic gastroparesis. 2004 Aliment. Pharmacol. Ther. pmid:15274670
Bai Y et al. Meta-analysis: erythromycin before endoscopy for acute upper gastrointestinal bleeding. 2011 Aliment. Pharmacol. Ther. pmid:21615438
Talley NJ et al. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. 2000 Aliment. Pharmacol. Ther. pmid:11121915
Emmanuel AV et al. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. 2004 Aliment. Pharmacol. Ther. pmid:15023171
Bell GD et al. Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori. 1992 Aliment. Pharmacol. Ther. pmid:1486161
Brand RM et al. Transdermal delivery of erythromycin lactobionate--implications for the therapy of gastroparesis. 1997 Aliment. Pharmacol. Ther. pmid:9218087
Minocha A et al. Erythromycin shortens orocaecal transit time in diabetic male subjects: a double-blind placebo-controlled study. 1995 Aliment. Pharmacol. Ther. pmid:8580273
Osato MS et al. Comparative efficacy of new investigational agents against Helicobacter pylori. 2001 Aliment. Pharmacol. Ther. pmid:11284777
Medhus AW et al. Low-dose intravenous erythromycin: effects on postprandial and fasting motility of the small bowel. 2000 Aliment. Pharmacol. Ther. pmid:10651665
Kendall BJ et al. The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post-vagotomy-antrectomy gastroparesis. 1997 Aliment. Pharmacol. Ther. pmid:9146779